Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 143.26
0.944 %
$ 14.5 B
Market Cap
38.2
P/E
NBIX - TOTAL DEBT REPAID
Total Debt Repaid NBIX - Neurocrine Biosciences, Inc.
0
LAST VALUE
41.42%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR